Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Highlights

COFUND-MSCA2020 : ApogeeBio chosen by the EC


Submitted by Genopole and its on-site partners, the ApogeeBio project for research grants has been selected by the European Commission for Marie Skłodowska-Curie Actions co-funding (MSCA-Cofund-2020).
COFUND MSCA 2020 - Results COFUND MSCA 2020 - Results

The co-financing from Europe and the active participation of the biocluster’s partners brings new dimensions to Genopole’s support for researchers: the number of grants will be doubled and mobility criteria extended to researchers the world over. ApogeeBio will thus contribute to the international visibility and renown of the scientific ecosystem in Évry and strengthen its European network.

The program is a financial lever to enable 24 two-year postdoctoral research grants over five years for life sciences, biotechnologies, informatics, and social sciences research focused on health and the environment.

ApogeeBio: a motor for the international attractiveness of the site’s labs and businesses

The site’s scientific partners (the University of Évry-Paris Saclay, CEA, Généthon, Télécom SudParis (TSP) and Institut Mines-Télécom Business School) and their supervisory bodies (UPSay, Inserm, CNRS, CEA, IMT) have committed themselves to this joint project to extend the research grant program and make it financially attractive to all international researchers.

The partners ABG Asso and Science-Accueil will accompany grant recipients to make sure that their arrival in Île-de-France and their immersion in French culture are as good as they can be and that their careers develop in the best possible conditions.

With the ApogeeBio program, laureates will benefit from a multidisciplinary research offer, specialized training and opportunities for public-private interactions with the site’s businesses and incubators.

European recognition for the territory’s research offer

With its support for the program, the European Commission recognized not only Genopole’s scientific capacities but also its ability to welcome and accompany young researchers within its ecosystem. Already a member of four European networks (European Cluster Collaboration Platform, EIT-Health, the Council for European Bioregions and EBN) and the only EU|BIC-certified cluster in Île-de-France, Genopole further consolidates its place as an international-scale biocluster with this vote of confidence by the European Union.

The ApogeeBio program extends Genopole’s welcome to researchers from all geographic and scientific horizons, and in so doing, enlarges and enriches the biocluster’s international research & innovation network.

Follow the calls for candidates and participate in future events

ApogeeBio will make three calls for proposals to young European researchers. The first will be in the second semester of 2021 for research projects to be launched in 2022.

A yearly scientific conference and career planning workshops will build relationships and enliven the network.

CitationKnowing that we can count on the shared efforts of our partners and the commitments of the supervisory bodies and the territories is a real advantage,” comments Genopole Research Project Manager Roxane Brachet.With five years of new European projects to come, ApogeeBio brings a new and durable dynamic to the site.

Contact

For more information on the ApogeeBio research grants

Roxane BRACHET

Scientific and Academic Development Manager
Research & Platforms Department
roxane.brachet@genopole.fr

Article posted on 8 February 2021

Share
Highlights

Latest news


Genhotel -  fibroblastes, cancer & Polyarthrite

Metabolic reprogramming involved in rheumatoid arthritis and cancer

The researchers from GenHotel (University of Évry-Paris Saclay, Genopole) have shed light on certain aspects common to rheumatoid arthritis and cancer.

Discover
AB Science L. Gros

Multiple sclerosis and COVID-19: promising results from AB Science

AB Science has been announcing a series of positive results concerning the efficacy of its product, masitinib, in such pathologies as multiple sclerosis, severe asthma resistant to oral steroids, COVID-19 and amyotrophic lateral sclerosis.

Discover
Placton - Tara Oceans

Bioinformatics and Tara Oceans

A team from the Genomics Metabolics Laboratory (Genoscope – CEA/CNRS/University of Évry) has developed a bioinformatics method for environmental genomics analyses able to identify species and associations of species.

Discover
Globules rouges - Avancées scientifiques

CRISPR-Cas9 for blood and metabolic diseases – Integrare

In an article published in Nature Communications, an Integrare team headed by Dr. Mario Amendola has described an innovative genome editing strategy aimed at modifying hematopoietic stem cells.

Discover
Généthon - Genopole's Laboratory

Treating more patients with gene therapies – Généthon

A Genethon team has successfully inhibited immune response to adeno-associated virus vectors, and in so doing, opened potential paths for treating more patients with gene therapies.

Discover
COVID-19 Disease Map

A single interactive map for all that is known on COVID-19

The objective for this latter is to build a sole referential comprising the totality of scientific knowledge on SARS-CoV-2/human-host interactions and thus contribute to the identification of therapeutic possibilities.

Discover
cellular membrane

Mapping membrane nanotubes – Lambe

A team from the Genopole-accredited Laboratory for Analysis and Modeling in Biology and the Environment (Lambe) has developed an experimental technique to study cell membrane nanotubes. These largely unknown structures play an essential role in cellular biomolecule transport.

Discover
Laboratory

Toward the industrialization of gene therapies -Polytheragene

Polytheragene is developing a polymer that will improve upon the current market standards for the production of viral particles for therapeutics. The polymer will be used by Genethon and Yposkesi to enhance the bioproduction of gene therapy vectors.

Discover
Jean Weissenbach

Jean Weissenbach: a portrait

Jean Weissenbach, a pioneer in France for the exploration of the human genome and a scientific icon at Genopole, talks about his career in an interview published 18 March 2020 in CNRS News.

Discover
cellular membrane

A nanopore to identify amino acids – Lambe

A team from the Laboratory for Analysis and Modeling in Biology and the Environment (Lambe – University of Évry/University of Cergy-Pontoise/CNRS) used a natural aerolysin nanopore to successfully identify 13 of the 20 amino acids that make up proteins.

Discover
Genopole - European projects

Green light from Europe for the Genopole-coordinated project GEN.ERA

Le projet européen GEN.ERA*, coordonné par Genopole, est sélectionné par la Commission européenne. Il vise à renforcer par une coopération entre clusters, l’internationalisation d’entreprises du secteur de la génomique au-delà du continent européen.

Discover
actus

New accomplishment in gene therapies

A clinical trial for a gene therapy to treat a severe immunodeficiency has provided highly promising initial results.

Discover
View all >
With support